Ischemic Stroke Pathogenesis: Genetics, Epigenetics and Inflammation

Author(s): Antonino Tuttolomondo

Journal Name: Current Pharmaceutical Design

Volume 26 , Issue 34 , 2020


Become EABM
Become Reviewer
Call for Editor

[1]
Tuttolomondo A, Daidone M, Pinto A. Endothelial dysfunction and inflammation in ischemic stroke pathogenesis. Curr Pharm Des 2020; 26(34): 4209-19.
[2]
Tuttolomondo A, Petta S, Casuccio A, et al. Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study. Cardiovasc Diabetol 2018; 17(1): 28.
[3]
Petta S, Tuttolomondo A, Gagliardo C, et al. The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease. Medicine (Baltimore) 2016; 95(16): e344.
[4]
Wong VW, Petta S, Hiriart JB, et al. Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. J Hepatol 2017; 67(3): 577-84.
[5]
Petta S, Adinolfi LE, Fracanzani AL, et al. Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis. J Hepatol 2018; 69(1): 18-24.
[6]
Petta S, Valenti L, Tuttolomondo A, et al. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease. Hepatology 2017; 66(6): 1885-93.
[7]
Jiang M, Yin P, Bai X, Yang L, Zhang J, Xu S. Proinflammatory and Anti-inflammatory genes in stroke pathogenesis. Curr Pharm Des 2020; 26(34): 4220-33.
[8]
Sarmah D, Datta A, Raut S, Sarkar A, et al. Role of inflammasomes in stroke and atherosclerosis pathogenesis. Curr Pharm Des 2020; 26(34): 4234-45.
[9]
Orellana-Urzúa S, Rojas I, Líbano L, Rodrigo R. Pathophysiology of ischemic stroke: role of oxidative stress. Curr Pharm Des 2020; 26(34): 4246-60.
[10]
Wei LK, Chow Y, Teh LK, Chih LH, Lim LF, Yee CC. Lipid metabolism genes in stroke pathogenesis: The Atherosclerosis. Curr Pharm Des 2020; 26(34): 4261-71.
[11]
Tuttolomondo A, Di Raimondo D, Pecoraro R, et al. HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke. J Neuroinflammation 2019; 16(1): 88.
[12]
Tuttolomondo A, Maida C, Pinto A. Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes. World J Orthop 2015; 6(1): 62-76.
[13]
Tuttolomondo A, Pecoraro R, Casuccio A, et al. Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers [published correction appears in Medicine (Baltimore) 2016 Jun 19; 94(24): 1.
[14]
Tuttolomondo A, Casuccio A, Guercio G, et al. Arterial stiffness, endothelial and cognitive function in subjects with type 2 diabetes in accordance with absence or presence of diabetic foot syndrome. Cardiovasc Diabetol 2017; 16(1): 2.
[15]
Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, Licata G. Risk factors profile and clinical outcome of ischemic stroke patients admitted in a Department of Internal Medicine and classified by TOAST classification. Int Angiol 2006; 25(3): 261-7.


free to download

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 34
Year: 2020
Published on: 12 October, 2020
Page: [4207 - 4208]
Pages: 2
DOI: 10.2174/138161282634200831110542

Article Metrics

PDF: 25
HTML: 3